IP Verse

Low Frequency Glatiramer Acetate Therapy - EP2949335

PATENT ANALYSIS

Patent Details

Grant Date
Jan 4, 2017
Company
YEDA RESEARCH & DEVELOPMENT COMPANY, LTD.
Oppositions

ALVOGEN IPCO S.A.R.L.

GENERICS [UK] LIMITED (TRADING AS MYLAN)

G. L. PHARMA GMBH

HEXAL AG

MYLAN TEORANTA TRADING AS MYLAN INSTITUTIONAL

SYNTHON B.V.

More patents of Yeda Research & Development Company, Ltd.

EP3409286

EP2630962

EP2949335

Want to monitor this patent?

Feel free to send us a message here and we will get back to you